Though biomarker testing is now considered standard of care for therapeutic decision making in cancer care, real-world evidence has identified several practice gaps, resulting in many patients not receiving biomarker testing results and/or matched targeted therapies. Marni Tierno, PhD, RN, discusses the latest publications addressing clinical practice gaps presented at the panel discussion workshop held at the Association for Molecular Pathology (AMP) meeting on November 20, 2024, in Vancouver, BC, Canada. Learn about insourcing NGS: https://youtu.be/eaAJ2zqm1uc Learn about in-house comprehensive genomic profiling (CGP): https://youtu.be/NErI9YCGcn4?si=ZLZ29OAM4KJUuwtw Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM LinkedIn: https://www.linkedin.com/company/illumina X: https://x.com/illumina Instagram: https://www.instagram.com/illuminainc/ Facebook: https://www.facebook.com/illuminainc TikTok: https://www.tiktok.com/@illuminainc #Illumina #NGS #biomarker #PrecisionMedicine